Instituto de Dermatologia Dona Libania, Fortaleza, Brazil Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT00669643
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

clofazimine (lamprene) (1 trial)

dapsone (aczone) (1 trial)

rifampin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leprosy (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3